Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | EPAS1 | Q99814 | 10/20 | 0.41 |
| ▸ | AHR | P35869 | 1/20 | 0.39 |
| ▸ | NQO2 | P16083 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31405023 | 1.00 | ALDH1A1 (0.46) | ALDH1A1EPAS1AHRNQO2TAAR1 | |
| SCHEMBL10875538 | 0.84 | LTA4H (0.45) | EPAS1AHR | |
| SCHEMBL186502 | 0.82 | ALDH1A1 (0.59) | ALDH1A1NQO2TAAR1 | |
| SCHEMBL168353 | 0.82 | ALDH1A1 (0.69) | ALDH1A1AHRNQO2TAAR1 | |
| SCHEMBL21263 | 0.82 | ALDH1A1 (0.69) | ALDH1A1AHRNQO2 | |
| SCHEMBL811578 | 0.82 | ALDH1A1 (0.59) | ALDH1A1AHR | |
| SCHEMBL5178645 | 0.80 | NFE2L2 (0.54) | ALDH1A1NQO2 | |
| SCHEMBL1816933 | 0.79 | ALDH1A1 (0.65) | ALDH1A1AHRNQO2 | |
| SCHEMBL28897626 | 0.77 | ALDH1A1 (0.50) | ALDH1A1EPAS1 | |
| SCHEMBL6832377 | 0.76 | MAPT (0.41) | EPAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090269674-A1 | ELECTROLYTE FOR LITHIUM BATTERY AND LITHIUM BATTERY COMPRISING SAME | SAMSUNG SDI CO., LTD. (KR) | 2009-10-29 | — | — | US | claimed |
| CN-100521357-C | Electrolyte for lithium battery and lithium battery containing the same | SAMSUNG SDI CO LTD (KR) | 2009-07-29 | — | — | CN | claimed |
| CN-100461525-C | Non aqueous electrolyte and lithium secondary cell using it | SAMSUNG SDI CO LTD (KR) | 2009-02-11 | — | — | CN | claimed |
| US-20070212614-A1 | Electrolyte for lithium battery and lithium battery comprising same | SAMSUNG SDI CO., LTD. (KR) | 2007-09-13 | — | — | US | claimed |
| US-7223500-B2 | Non-aqueous electrolyte and a lithium secondary battery comprising the same | SAMSUNG SDI CO., LTD. (KR) | 2007-05-29 | — | — | US | claimed |
| US-20040197667-A1 | Non-aqueous electrolyte and a lithium secondary battery comprising the same | SAMSUNG SDI CO., LTD. (KR) | 2004-10-07 | — | — | US | claimed |
| EP-1463143-A2 | A non-aqoeous electrolyte and a lithium secondary battery comprising the same | Samsung SDI Co., Ltd. (KR) | 2004-09-29 | — | — | EP | claimed |
| CN-1532986-A | Non aqueous electrolyte and lithium secondary cell using it | ����SDI��ʽ���� | 2004-09-29 | — | — | CN | claimed |
| CN-1449070-A | Electrolyte for lithium battery and lithium battery containing the same | SAMSUNG SDI CO LTD (KR) | 2003-10-15 | — | — | CN | claimed |
| US-20030190529-A1 | Electrolyte for lithium battery and lithium battery comprising same | SAMSUNG SDI CO., LTD. (KR) | 2003-10-09 | — | — | US | claimed |
| US-11071736-B2 | Modulators of HEC1 activity and methods therefor | TAIVEX THERAPEUTICS CORPORATION | 2021-07-27 | — | — | US | disclosed |
| US-11071736-B2 | Modulators of HEC1 activity and methods therefor | TAIVEX THERAPEUTICS CORPORATION | 2021-07-27 | — | — | US | disclosed |
| US-10588909-B2 | Modulators of HEC1 activity and methods therefor | TAIVEX THERAPEUTICS CORPORATION (TW) | 2020-03-17 | — | — | US | disclosed |
| US-20190002448-A1 | SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF | Karyopharm Therapeutics Inc. | 2019-01-03 | — | — | US | disclosed |
| EP-2785714-B1 | IMPROVED MODULATORS OF HEC1 ACTIVITY AND METHODS THEREFOR | TAIVEX THERAPEUTICS CORP (TW) | 2018-11-21 | — | — | EP | disclosed |
| US-20040197667-A1 | Non-aqueous electrolyte and a lithium secondary battery comprising the same | SAMSUNG SDI CO., LTD. (KR) | 2004-10-07 | — | — | US | disclosed |
| EP-1463143-A2 | A non-aqoeous electrolyte and a lithium secondary battery comprising the same | Samsung SDI Co., Ltd. (KR) | 2004-09-29 | — | — | EP | disclosed |
| CN-1532986-A | Non aqueous electrolyte and lithium secondary cell using it | ����SDI��ʽ���� | 2004-09-29 | — | — | CN | disclosed |
| CN-1449070-A | Electrolyte for lithium battery and lithium battery containing the same | SAMSUNG SDI CO LTD (KR) | 2003-10-15 | — | — | CN | disclosed |
| US-20030190529-A1 | Electrolyte for lithium battery and lithium battery comprising same | SAMSUNG SDI CO., LTD. (KR) | 2003-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190002448-A1 | SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF | BCL6, MALT1, BCL3 | ALDH1A1 530/4885EPAS1 3090/4885AHR 289/4885 |
| US-10588909-B2 | Modulators of HEC1 activity and methods therefor | WEE1, WEE2, NEK11 | ALDH1A1 3121/4885EPAS1 102/4885AHR 3191/4885 |
| US-11071736-B2 | Modulators of HEC1 activity and methods therefor | WEE1, WEE2, NEK11 | ALDH1A1 3121/4885EPAS1 102/4885AHR 3191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.